The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2667715
WO Application Number:
US2012000047
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12739509.3
WO Publication Number:
WO2012102832
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
New Zealand (NZ)
Publications:
Dates
Filing date:
27/01/2012
Grant date:
19/07/2017
EP Publication Date:
04/12/2013
WO Publication Date:
02/08/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
13/10/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/07/2017
EP B1 Publication Date:
19/07/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/01/2032
Lapsed By Expiration Date:
Patent Validated Date:
28/10/2017
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
19/07/2017
Name:
Neuren Pharmaceuticals Limited
Address:
Lowndes Jordan
Level 15 PWC Tower
188 Quay Street, Auckland 1141, New Zealand (NZ)
Domicile Holder
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
13/10/2017
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)